Cornelis P Allaart
Overview
Explore the profile of Cornelis P Allaart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
1094
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burger J, Hopman L, Campos F, Allaart C, Postema P, Kemme M, et al.
Heart Rhythm
. 2025 Mar;
PMID: 40089050
Background: Late gadolinium enhancement (LGE) images, reconstructed using magnitude (MAG) or phase-sensitive inversion recovery (PSIR), differ in signal intensities due to their handling of longitudinal magnetization. These differences influence LGE...
2.
Selder J, Mulder M, van de Vijver W, Croon P, Wentrup L, van der Pas S, et al.
PLOS Digit Health
. 2024 Dec;
3(12):e0000688.
PMID: 39705212
Objective: This study aimed to assess whether providing AF patients with a 1-lead ECG device for 1 year after PVI would reduce ED utilization compared to standard care. Additionally, the...
3.
Olde Nordkamp L, Pepplinkhuizen S, Ghani A, Boersma L, Kuschyk J, El-Chami M, et al.
Circ Arrhythm Electrophysiol
. 2024 Dec;
17(12):e012836.
PMID: 39624908
Background: Inappropriate therapy (IAT) is an undesirable side effect of implantable cardiac defibrillator (ICD) therapy. Early studies with the subcutaneous ICD (S-ICD) showed relatively high inappropriate shock (IAS) rates. The...
4.
Croon P, van Vugt M, Allaart C, Ruijsink B, Elliott P, Asselbergs F, et al.
medRxiv
. 2024 Nov;
PMID: 39606349
Background: Patients with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) exhibit structural and functional cardiac abnormalities. We aimed to identify imaging biomarkers for pre-clinical cardiomyopathy in healthy individuals carrying cardiomyopathy-associated...
5.
Knops R, de Veld J, Ghani A, Boersma L, Kuschyk J, El Chami M, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Nov;
17(11):e010822.
PMID: 39561235
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to overcome the risk of lead-related complications associated with the transvenous implantable cardioverter-defibrillator (TV-ICD). In contrast to the TV-ICD, the S-ICD is...
6.
Burger J, Hopman L, Kemme M, Hoeksema W, Takx R, Figueras I Ventura R, et al.
Heart Rhythm O2
. 2024 Sep;
5(8):561-572.
PMID: 39263615
Ventricular tachycardia (VT) is a life-threatening heart rhythm and has long posed a complex challenge in the field of cardiology. Recent developments in advanced imaging modalities have aimed to improve...
7.
Hopman L, van Slochteren F, Konings T, Rondanina E, Allaart C, Gotte M, et al.
Eur Heart J Imaging Methods Pract
. 2024 Sep;
2(3):qyae083.
PMID: 39229459
No abstract available.
8.
Kolk M, Ruiperez-Campillo S, Allaart C, Wilde A, Knops R, Narayan S, et al.
Sci Rep
. 2024 Jun;
14(1):14889.
PMID: 38937555
The efficacy of an implantable cardioverter-defibrillator (ICD) in patients with a non-ischaemic cardiomyopathy for primary prevention of sudden cardiac death is increasingly debated. We developed a multimodal deep learning model...
9.
van Pouderoijen N, Hopman L, Hofman M, de Groot J, Kemme M, Allaart C, et al.
JACC Clin Electrophysiol
. 2024 Jun;
10(8):1929-1931.
PMID: 38904573
No abstract available.
10.
Van Der Lingen A, Verstraelen T, van Erven L, Meeder J, Theuns D, Vernooy K, et al.
Neth Heart J
. 2024 Apr;
32(5):190-197.
PMID: 38634993
International guidelines recommend implantation of an implantable cardioverter-defibrillator (ICD) in non-ischaemic cardiomyopathy (NICM) patients with a left ventricular ejection fraction (LVEF) below 35% despite optimal medical therapy and a life...